Interview with Xander Bos, General Manager, Boehringer Ingelheim B.V.
28.07.2012
Related Interviews
Europe / EMA's Emer Cooke Talks COVID Lessons, AMR & Clinical Trials
In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the COVID-19 pandemic response, outlines the…
Interview: Karel Fol – Country Manager Benelux, Sobi, The Netherlands
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease patients and their families. Karel Fol, the country manager…
Interview: Leo De Haan – Managing Director Benelux, Aurobindo, The…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in the Netherlands, the resulting second pillar of specialty products for the…
UK / Life Sciences Plan Takes Shape; Record Rise in Private Healthcare Use; MHRA’s New Regulatory Recognition Routes
The latest news from UK healthcare and the life sciences, including a record rise in the number of people using private healthcare services due to significant strains on the National…
Greece / Pharma Talent: Brain Regain in Action?
Greece’s deep and painful sovereign debt crisis lasted almost a decade and saw up to 500,000 Greeks leave the country in search of opportunities elsewhere as the country’s economy shrunk…
Europe / 4 Key Priorities for the European Medicines Agency in 2023
As part of a wide-ranging conversation with PharmaBoardroom published earlier this month, European Medicines Agency (EMA) Executive Director Emer Cooke laid out four of the Agency’s core focus areas for…
